文献速递头颈外科

姑息性大分割放疗剂量对不可治愈头颈癌的缓解预测价值

Importance of dose in palliative treatment for incurable head and neck cancer with radiotherapy.
PubMed 文献 · Head Neck · 2020-12-15

该回顾性研究纳入106例不可治愈头颈癌患者,接受「Hypo Trial」大分割放疗方案(30-36Gy,分5-6次,每次6Gy,双周照射)。中位随访6.92个月,79.2%患者获得临床缓解,缓解与放疗剂量相关(P=0.05),且缓解与总生存相关(P=0.01)。

要点

  • 30-36Gy/5-6次大分割方案姑息缓解率达79.2%,完成率89.6%。
  • 放疗剂量是姑息缓解的预测因素(P=0.05)。
  • 获得姑息缓解与总生存改善相关(P=0.01)。

核心结论

  • 短程姑息性大分割放疗方案获得高缓解率、良好依从性和可接受的毒性。
  • 放疗剂量是姑息缓解的预测因素。

研究设计与样本

  • 放疗方案为30-36Gy,分5-6次,每次6Gy,双周照射。

主要发现

  • 处方剂量30Gy者57例(53.8%),36Gy者49例(46.2%)。
  • 89.6%患者完成预定治疗。
  • 中位随访6.92个月,79.2%患者获得临床缓解。
  • 缓解与放疗剂量相关(P=0.05)。
  • 中位总生存7个月,中位无进展生存4.63个月;获得缓解与总生存相关(P=0.01)。

临床怎么用

  • 对不可治愈头颈癌患者,可考虑短程大分割姑息放疗方案。
  • 放疗剂量选择需权衡姑息缓解获益与毒性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To identify predictors of palliation for head and neck cancer treated with the "Hypo Trial" hypofractionated radiation therapy regimen in a clinical setting. DESIGN/METHOD: We retrospectively assessed 106 consecutive patients with incurable cancer, treated between January 2008 and December 2018. Regimen used was 30-36Gy in 5-6 biweekly fractions of 6Gy. RESULTS: The prescription dose was 30Gy in 57 (53.8%) patients and 36Gy in 49 (46.2%) patients. 89.6% patients completed the prescribed treatment. With a median follow-up of 6.92 months, 79.2% of the patients experienced clinical palliation. Palliation was correlated with the radiation therapy dose (P = 0.05). Median overall and progression-free survival (OS, PFS) were 7 and 4.63 months, respectively. Achieving palliation was associated to OS (P = 0.01). CONCLUSIONS: This short palliative hypofractionated scheme resulted in a high rate of palliation, with excellent compliance and acceptable toxicity. Our results show that radiation dose is a predictive factor for palliation.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. García-Anaya MJ, Ordoñez R, Toledo MD, et al. Importance of dose in palliative treatment for incurable head and neck cancer with radiotherapy. Head Neck. 2020. PMID: 33325113. doi:10.1002/hed.26555

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。